Biopharmaceuticals Flashcards

1
Q

What are the types of biopharmaceuticals?

A

Cytokines, Antibody, T cell, Checkpoint inhibition, Vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does IFN-a do?

A

Promotes antiviral and antiproliferative state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IFN-a is produced by which cells?

A

Leukocytes (but not constitutively present in large amounts - inducible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does IFN-B do?

A

Inhibits IFN-gamma. Slows growth of attacking immune cells. Stops production of myelin degrading compounds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IFN-B is secreted by which cells?

A

Somatic cells, fibroblasts, epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does IFN-gamma do?

A

Activates resting macrophages and monocytes to increase their phagocytic activity. Induces macrophages to xp cytokines, MHC proteins and Ig Fc rece.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IFN-gamma is secreted by which cell?

A

T lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does IL-2 do?

A

Activation of B, T, NK cells via autocrine and paracrine effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does IL-11 do?

A

Stimulate proliferation of hematopoietic stem cells and induce megakaryocyte maturation –> increase platelet formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What effect does G-CSF have?

A

Stimulates neutrophil proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What effect does GM-CSF have?

A

Stimulates neutrophil, eosinophil and monocyte proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which type of antibody has murine Vh, Vl and human Ch,Cl, Fc?

A

Chimeric mab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which type of antibody is entirely human other than murine CDR?

A

Humanised mab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fill in the blank.

Humanised mab is ___% human

A

90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fill in the blank.

Chimeric mab is __% human

A

75

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What types of antibody derivatives are there?

A

Antibody conjugate. (Fab)2. Fab. ScFv. Bispecific T cell engagers (BiTe). Trifunctional mab (Triomab). Defucosylated.

17
Q

What is TCR-T?

A

Genes coding for Va, VB regions of antigen specific TCR transduced into T cells isolated from patients. TCR expressed on T cell. Expand & reinfuse. TCR-T T cells bind to antigens, activate T cells.

18
Q

What is CAR-T?

A

Genes coding for Vh, Vl of antigen specific Ig are transduced into T cells. scFv (Vh, Vl) expressed on surface of T cells, expanded and reinfused. CAR-T T cell binds to antigens, triggering T cell cytotoxic activity.

19
Q

What therapy may work independent of MHC expression?

A

CAR-T

20
Q

Which T cell therapy works slower, but is more long lasting?

A

TCR-T

21
Q

What are the limitations of short peptides in peptide vaccines?

A
22
Q

What components are involved in the 1st generation of CAR-T?

A

Only TCR, CD3(S)

23
Q

What components are involved in the 2nd generation of CAR-T?

A

TCR, CD3(S) co-stimulatory CD28 or 4-1BB intracellular proteins

24
Q

What components are involved in the 3rd generation of CAR-T?

A

TCR, CD3(S) both co-stimulatory CD28 and 4-1BB intracellular proteins

25
Q

What components are involved in the 4th generation of CAR-T?

A

TCR, CD3(S), both co-stimulatory CD28 and 4-1BB intracellular protein, transgene.
Binding of antigen triggers expression of transgene. This increases IL-2 which has anti-tumour function and activate more T cells to kill cancer cells.

26
Q

Which generation(s) of CAR-T therapy can act on neo-antigen negative cancer cells?

A

4th generation. The production of IL-2 may act on neo-antigen negative cancer cells.